CBOA
CBST

Commonwealth Bank of Australia’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Commonwealth Bank of Australia’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,381
Closed -$247K – 1210
2014
Q1 		$247K Sell
3,381
-57
-2% -$4.25K ﹤0.01% 1178
2013
Q4 		$237K Buy
+3,438
New +$223K ﹤0.01% 1158
2013
Q3 		– Sell
-2,400
Closed -$116K – 1348
2013
Q2 		$116K Buy
+2,400
New +$118K ﹤0.01% 1169

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Commonwealth Bank of Australia's CBST Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q2 2014, closing a stake of 3,381 shares — an estimated $247K sold.

Commonwealth Bank of Australia first reported a position in CBST in Q2 2013 and held it in 3 quarters. The position peaked at $247K in Q1 2014. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

  • Commonwealth Bank of Australia reported no remaining CUBIST PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 3,381 CUBIST PHARMACEUTICALS INC shares in Q2 2014, an estimated $247K.
  • Commonwealth Bank of Australia first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 3 quarters.
  • Commonwealth Bank of Australia's CUBIST PHARMACEUTICALS INC position peaked at $247K in Q1 2014.
  • 270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.